Azitra, Inc. (NYSEAMERICAN:AZTR – Free Report) shares are set to reverse split before the market opens on Monday, July 1st. The 1-30 reverse split was announced on Monday, July 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, July 1st.
Azitra Stock Down 30.2 %
Shares of AZTR opened at $0.09 on Friday. Azitra has a fifty-two week low of $0.09 and a fifty-two week high of $4.33. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.80 and a current ratio of 2.80.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last posted its earnings results on Thursday, May 9th. The company reported ($0.15) EPS for the quarter. Azitra had a negative net margin of 1,644.90% and a negative return on equity of 237.52%.
Azitra Company Profile
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Further Reading
- Five stocks we like better than Azitra
- What is Put Option Volume?
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Where Do I Find 52-Week Highs and Lows?
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- 5 Top Rated Dividend Stocks to Consider
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
